Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety
Research output: Contribution to journal › Review › Research › peer-review
Documents
- Guselkumab for hidradenitis suppurativa in a patient with concomitant
Final published version, 451 KB, PDF document
Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.
| Original language | English |
|---|---|
| Journal | Clinical Case Reports |
| Volume | 8 |
| Issue number | 12 |
| Pages (from-to) | 2874-2877 |
| Number of pages | 4 |
| ISSN | 2050-0904 |
| DOIs | |
| Publication status | Published - 2020 |
- Crohn's disease, guselkumab, Hidradenitis suppurativa, inflammation
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 249860508